Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 1.9. It has been cited 53 times, with 46 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.598
From this paper's citation signal
Citation Network Contribution
1.3
From 37 citing papers with measurable signal
NCI NIH HHS
Grant: P01 CA244118
NCI NIH HHS
Grant: R35 CA197633
National Institutes of Health
Grant: 1P01CA244118-01A1
Combination Therapies to Defeat Melanoma Resistance
National Institutes of Health
Grant: 5R01CA142779-03
B7-H1/PD-1 modulation in cancer therapy
National Institutes of Health
Grant: 2R35CA197633-08
Next Generation Cancer Immunotherapies to Defeat Melanoma
National Institutes of Health
Grant: 5R01CA121113-04
Large-scale Genetic Analyses of Gene Families in Colorectal Cancer
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 3P30CA016042-35S3
Cancer Center Support Grant
National Institutes of Health
Grant: 3UG1CA233259-06S1
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
National Institutes of Health
Grant: 5T32CA009120-45
UCLA Tumor Immunology Institutional Traning Grant
Fields of Study
Keywords
Sustainable Development Goals